Free release
5-((E)-2-Bromovinyl)-1-((2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)pyrimidine-2,4(1H

5-((E)-2-Bromovinyl)-1-((2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)pyrimidine-2,4(1H

CAS No. :69304-47-8MDL No. :MFCD00058585Formula :C11H13BrN2O5Boiling Point :-Linear Structure Formula :-InChI Key :ODZBB

Sales:Service@apichina.com
CAS No. :69304-47-8 Brand :Qitai
Formula :C11H13BrN2O5 M.W :333.14

Introduction

CAS No. :69304-47-8 MDL No. :MFCD00058585
Formula : C11H13BrN2O5 Boiling Point : -
Linear Structure Formula :- InChI Key :ODZBBRURCPAEIQ-PIXDULNESA-N
M.W : 333.14 Pubchem ID :446727
Synonyms :
Brivudine;Bromovinyldeoxyuridine;BVDU
Chemical Name :5-((E)-2-Bromovinyl)-1-((2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)pyrimidine-2,4(1H,3H)-dione

Physicochemical Properties

Num. heavy atoms : 19
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.45
Num. rotatable bonds : 3
Num. H-bond acceptors : 5.0
Num. H-bond donors : 3.0
Molar Refractivity : 71.07
TPSA : 104.55 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : No
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -8.63 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.29
Log Po/w (XLOGP3) : -0.42
Log Po/w (WLOGP) : -0.89
Log Po/w (MLOGP) : -0.93
Log Po/w (SILICOS-IT) : 0.69
Consensus Log Po/w : -0.05

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 0.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -1.68
Solubility : 7.02 mg/ml ; 0.0211 mol/l
Class : Very soluble
Log S (Ali) : -1.31
Solubility : 16.3 mg/ml ; 0.0489 mol/l
Class : Very soluble
Log S (SILICOS-IT) : -0.97
Solubility : 35.9 mg/ml ; 0.108 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 0.0
Synthetic accessibility : 3.94
Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H302-H315-H319 Packing Group:N/A
GHS Pictogram: